Cactus Life Sciences Announces the Acquisition of Nspm and EluSCIdate
Cactus Life Sciences Announces the Acquisition of Nspm and EluSCIdate
nspm's rare disease expertise and global event proficiency expand Cactus Life Sciences' services amidst exciting buy-and-build strategy
nspm 的罕见病专业知识和全球活动熟练程度在激动人心的 “买进建造” 战略中扩展了 Cactus Life Sciences 的服务
PRINCETON, NJ / ACCESSWIRE / April 24, 2024 / Cactus Life Sciences, a leading global scientific communications agency that works with blue chip pharma and biotechnology companies, announced today that they have acquired nspm and eluSCIdate, two dynamic medical communications and publications companies headquartered in Meggen, Switzerland with an office in the UK.
新泽西州普林斯顿/ACCESSWIRE/2024年4月24日/与蓝筹制药和生物技术公司合作的全球领先科学传播机构Cactus Life Sciences今天宣布，他们已经收购了总部位于瑞士梅根并在英国设有办事处的两家动态医疗传播和出版公司nspm和eLuscidate。
logo lock up of nspm and eluSCIdate
nspm 和 eLusciDate 的徽标锁定
Cactus Life Sciences, headquartered in Princeton, New Jersey, was formed in 2010 and is best known for its transformational global operating models that provide best in class science, innovation, and efficiency. Founded 27 years ago, nspm brings extensive expertise in medical communications, publications, and event management, with a focus on rare diseases. Its sister company eluSCIdate was founded in 2020 and focuses on medical and scientific publications, combining extensive experience in medical writing with creative flair to deliver high-quality publications.
Cactus Life Sciences总部位于新泽西州普林斯顿，成立于2010年，以其提供一流科学、创新和效率的变革性全球运营模式而闻名。nspm 成立于 27 年前，在医学传播、出版物和活动管理方面拥有丰富的专业知识，专注于罕见疾病。其姊妹公司eLusciDate成立于2020年，专注于医学和科学出版物，将丰富的医学写作经验与创造性天赋相结合，提供高质量的出版物。
This collaboration signifies a major step forward in enhancing services for our biopharma clients, ensuring a comprehensive and fully integrated global approach to medical communications. And provides a significant employee footprint in US, UK, Switzerland, and Japan.
此次合作标志着在加强为我们的生物制药客户提供的服务，确保采用全面和完全整合的全球医疗通信方法方面向前迈出了重要一步。并在美国、英国、瑞士和日本提供大量员工。
"As Cactus Life Sciences embarks on its forthcoming buy-and-build strategy, we're excited to unveil our first acquisition that shares so many of the same values as CACTUS, stated Oliver Dennis, the new Chairman of Cactus Life Sciences. "As we move forward, we seek partnerships that prioritize our people and clients alongside our strategic growth."
仙人掌生命科学新任董事长奥利弗·丹尼斯表示：“在Cactus Life Sciences开始其即将推出的收购和建造战略之际，我们很高兴宣布我们的第一笔收购，该收购与CACTUS有许多相同的价值。”“在我们向前迈进的过程中，我们寻求合作伙伴关系，在战略增长的同时优先考虑我们的员工和客户。”
Rare diseases individually affect a small number of people, but collectively affect over 300 million worldwide, presenting significant challenges for patients and medical professionals. nspm's rare disease expertise addresses unmet needs for patients and society. Sabine Stotz, PhD, Managing Director, nspm, noted "This strategic alliance is a testament to the shared vision of excellence between Cactus Life Sciences, nspm and eluSCIdate. Together, our goal is to enrich the global landscape of scientific communications creating an even greater impact on healthcare professionals and the patients they treat."
罕见疾病单独影响少数人，但共同影响全球超过3亿人，这给患者和医疗专业人员带来了重大挑战。nspm的罕见病专业知识可以解决患者和社会未得到满足的需求。nspm董事总经理萨宾·斯托兹博士指出：“这种战略联盟证明了Cactus Life Sciences、nspm和eLusciDate之间共同的卓越愿景。我们的共同目标是丰富全球科学传播格局，对医疗保健专业人员及其治疗的患者产生更大的影响。”
Elvira Dsouza, President, Cactus Life Sciences remarked, "Cactus Life Sciences stands out for its unwavering commitment to excellence, innovation, and future readiness. With a focus on integrating cutting-edge technology, notably AI, we aim to elevate scientific content creation to contribute to a more accessible, informed, and transformative healthcare landscape."
仙人掌生命科学总裁埃尔维拉·德索扎表示：“仙人掌生命科学因其对卓越、创新和为未来做好准备的坚定承诺而脱颖而出。我们专注于整合尖端技术，尤其是人工智能，旨在提升科学内容创作，为更容易获得、更知情和更具变革性的医疗保健格局做出贡献。”
About Cactus Life Sciences (cactuslifesciences.com): Cactus Life Sciences is a medical communication company that provides scientific strategy and content across the healthcare continuum, anywhere in the world - with a focus on science, innovation, and efficiency. We work alongside leading healthcare companies to establish the optimal role of medicines and encourage positive behaviors (physician and patient) that improve patient outcomes.
关于仙人掌生命科学（cactuslifesciences.com）：Cactus Lifesciences是一家医疗传播公司，在世界任何地方提供医疗保健领域的科学战略和内容，重点是科学、创新和效率。我们与领先的医疗保健公司合作，确定药物的最佳作用，鼓励积极的行为（医生和患者）以改善患者预后。
About nspm (): nspm is a successful and dynamic medical communications company founded in 1997 with offices in Switzerland and the UK. nspm provides a complete range of medical writing, project management, and strategic medical communications solutions for the pharmaceutical and biotech industry across a range of therapeutic areas, with a focus on rare diseases. Our employees are committed to crafting high-quality, cost-effective solutions that exceed clients' expectations through scientific excellence, professionalism, and creativity.
关于 nspm ()：nspm 是一家成功且充满活力的医疗传播公司，成立于 1997 年，在瑞士和英国设有办事处。nspm 为制药和生物技术行业提供涵盖一系列治疗领域的全方位医学写作、项目管理和战略医学传播解决方案，重点关注罕见疾病。我们的员工致力于通过卓越的科学、专业精神和创造力打造高质量、具有成本效益的解决方案，这些解决方案超出了客户的期望。
About eluSCIdate (): eluSCIdate is a medical writing agency founded in 2020 that specializes in scientific publications, providing support for the entire publication process. We use a wealth of experience in medical writing to deliver high-quality manuscripts, posters, and slides to our clients. At eluSCIdate, we are passionate about science and committed to providing clarity in scientific messaging. Through effective communication, we work with our clients to ensure their science stands out from the crowd.
关于eLusciDate ()：eLusciDate是一家医学写作机构，成立于2020年，专门出版科学出版物，为整个出版过程提供支持。我们利用丰富的医学写作经验为客户提供高质量的手稿、海报和幻灯片。在 eLusciDate，我们对科学充满热情，并致力于提供清晰的科学信息。通过有效的沟通，我们与客户合作，确保他们的科学在人群中脱颖而出。
Contact Information
联系信息
Laura Perry
VP of Strategy and Marketing
inquiries@cactuslifesciences.com
7327121005
劳拉·佩里
战略与营销副总裁
inquiries@cactuslifesciences.com
7327121005
SOURCE: Cactus Life Sciences
来源：仙人掌生命科学
译文内容由第三方软件翻译。